Why It’s Important to Be a Well-Educated, Proactive Patient

Video

Patients with cancer can advocate for themselves by researching their illnesses and treatments before an appointment, so they’re able to ask better questions, says an expert from the HealthTree Foundation for Multiple Myeloma.

Patients with cancer often look for ways to empower themselves as they navigate the uncertainty of their cancer journey. According to Jenny Ahlstrom, who lives with multiple myeloma, one way to feel more empowered is to educate yourself on your disease as much as possible.

In an interview with CURE®, Ahlstrom, who launched the HealthTree Foundation for Multiple Myeloma, explained how doing proper research on your cancer type can lead to better outcomes.

“I feel like the work I've done has helped me and brought me a lot of joy in service of other patients,” Ahlstrom said. “But it's also empowered other people to ask better questions... You’re getting better outcomes when you educate yourself about your own disease. You will, because you'll ask better questions in your clinic.”

Transcription:

I think the idea that patients can make more of a difference than they've ever thought is a reality. I feel like the work I've done has helped me and brought me a lot of joy in service of other patients. But it's also empowered other people to ask better questions. They’re getting better outcomes.

You’re getting better outcomes when you educate yourself about your own disease. You will, because you'll ask better questions in your clinic. And you won’t ask basics like “What's a light chain” and your doctor has to spend 20 minutes explaining what a light chain is. (You can) go do that elsewhere, so you come into the office prepared, and then you can contribute.

So, I feel like we're inviting all these patients to contribute to a myeloma cure instead of sitting back and waiting for a myeloma cure. And I think patients can do that for any disease.

Editor's Note: Myeloma Crowd is now known as HealthTree Foundation for Multiple Myeloma.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE